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Here, we review current data elucidating the role of red blood cell derived microparticles
(RMPs) in normal vascular physiology and disease progression. Microparticles (MPs)
are submicron-size, membrane-encapsulated vesicles derived from various parent cell
types. MPs are produced in response to numerous stimuli that promote a sequence
of cytoskeletal and membrane phospholipid changes and resulting MP genesis. MPs
were originally considered as potential biomarkers for multiple disease processes and
more recently are recognized to have pleiotropic biological effects, most notably in:
promotion of coagulation, production and handling of reactive oxygen species, immune
modulation, angiogenesis, and in initiating apoptosis. RMPs, specifically, form normally
during RBC maturation in response to injury during circulation, and are copiously
produced during processing and storage for transfusion. Notably, several factors during
RBC storage are known to trigger RMP production, including: increased intracellular
calcium, increased potassium leakage, and energy failure with ATP depletion. Of note,
RMP composition differs markedly from that of intact RBCs and the nature/composition
of RMP components are affected by the specific circumstances of RMP genesis.
Described RMP bioactivities include: promotion of coagulation, immune modulation,
and promotion of endothelial adhesion as well as influence upon vasoregulation via
influence upon nitric oxide (NO) bioavailability. Of particular relevance, RMPs scavenge
NO more avidly than do intact RBCs; this physiology has been proposed to contribute to
the impaired oxygen delivery homeostasis that may be observed following transfusion.
In summary, RMPs are submicron particles released from RBCs, with demonstrated
vasoactive properties that appear to disturb oxygen delivery homeostasis. The clinical
impact of RMPs in normal and patho-physiology and in transfusion recipients is an area
of continued investigation.
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MICROPARTICLES (MP) OVERVIEW
Genesis of small membrane-encapsulated vesicles (termed microparticles, MPs) from activated
and/or apoptotic cells was first reported ∼40 years ago (Boulanger and Dignat-George,
2011). Formally defined, MPs are cell-derived vesicles that are 0.1–1.0µm in size and are
categorized by membrane proteins and cytosolic material that is specific to various parent cell
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populations (Morel et al., 2011; Figure 1). MPs are distinguished
from exosomes and apoptotic bodies by size, composition and
mechanism of formation (Burger D. et al., 2013; Figure 2).
Exosomes are generally smaller (40–100 nm) and form by a
multistep process that involves intracellular generation and
subsequent vesicle extrusion; apoptotic bodies are much larger
(1–5µm) and arise via shedding during apoptosis (Elmore,
2007).
Cell-Cell Communication via MPs:
MPs serve as vehicles for inter-cellular exchange of biological
material and information, for which two principle mechanisms
have been proposed: (1) MPs act as circulating modules
for complex signaling, activating receptors on target cells by
presenting organized clusters of membrane-associated bioactive
molecules (Del Conde et al., 2005), and/or (2) direct transfer
of MP contents, including proteins, bioactive lipids or RNA to
recipient cells—thereby, promoting phenotypic modification and
reprogramming of cell functions (Whale et al., 2006). As such,
MP based cell-cell communication enables a unique form of
remote signaling from MP-parent to target cells, by presenting
a complex array of ligands for membrane receptors, paired with
a concentrated payload of bioactive molecules and substrate for
intracellular delivery (Mause and Weber, 2010).
MPs as Disease Biomarkers
MP formation is enhanced by stress and injury and consequently,
MPs have been considered as potential biomarkers for disease
onset and progression. As such, it is important to recognize that
moment-specific abundance of circulating MPs is determined
by the balance between MP formation and clearance (e.g., MP
abundance and flux do not necessarily correlate and, high-flux
low-abundance states may have physiologic significance that is
belied by measured MP level, alone.). MP levels, in particular: for
platelet-, leukocyte-, and endothelium-related MPs, are known
to increase in the setting of vascular injury, pro-thrombotic
and pro-inflammatory states that complicate a broad array of
health conditions, such as diabetes (Feng et al., 2010), pulmonary
hypertension (Forest et al., 2010), chronic kidney disease (Faure
et al., 2006), preeclampsia (González-Quintero et al., 2003),
atherosclerosis (Bernal-Mizrachi et al., 2003), and heart failure
(Amabile et al., 2012) amongst others.
MP Formation
MPs arise from diverse cell types, including vascular elements
(endothelial and vascular smooth muscle cells) (Rautou et al.,
2011), blood components [erythrocytes (Tissot et al., 2010),
platelets and leukocytes], cardiomyocytes (Antoniak et al., 2009)
and podocytes (Burger D. et al., 2013), as well as various cancers
(Zahra et al., 2011) and progenitor cell populations (Chen
et al., 2010). MPs form via outward blebbing and shedding of
the plasma membrane (Dignat-George and Boulanger, 2011).
This poorly understood process appears to involve two main
steps: (1) an initial cytoskeletal re-organization (Cauwenberghs
et al., 2006), involving actin filament rearrangement that appears
initiated by activation of calpain (Nolan et al., 2008), rho kinase
(Sapet et al., 2006), and transglutaminase (van den Akker et al.,
2012; Figure 3) and (2) externalization of phosphatidylserine
(PS), a negatively charged aminophospholipid found almost
exclusively on the plasma membrane inner leaflet, in healthy
cells (Bevers et al., 1999). In red blood cells, PS “sidedness” is
controlled by an ATP/calcium dependent system involving three
distinct enzymes: flippase, floppase, and scramblase (Kostova
et al., 2015). Of note, defective PS externalization underlies
Scott syndrome, a bleeding disorder associated with diminished
platelet MP shedding (Leroyer et al., 2009).
Studies of cultured cells have identified several stimuli for
MP formation, including: various hormones, fatty acids, reactive
oxygen species (e.g., hydrogen peroxide) (Aoki et al., 2007)
as well as increased intracellular calcium (Fox et al., 1991).
Activation of several surface receptors has also been shown to
drive MP production, such as by tumor necrosis factor (TNF)-
α (Eyre et al., 2011) on monocytes, leukocytes, and neutrophils,
as well as by pro-inflammatory [lipopolysaccharide (Ståhl et al.,
2011), shiga toxin (Ståhl et al., 2011), and cytokines (Nomura
et al., 2000)] and pro-coagulant ligands [thrombin (Terrisse
et al., 2010), collagen (Takano et al., 2004), and norepinephrine
(Tschuor et al., 2008)] on platelets and Toll-like receptor 4 on
dendritic cells (Théry et al., 2009; Figure 4).
MP Clearance
MP elimination via the mononuclear phagocyte system (MPS)
appears to regulate circulating MP availability for target-cell
fusion; however, less is known about this process than about
MP formation (Burger D. et al., 2013). Macrophages ingest co-
culturedMPs and externalized PS is thought to activate scavenger
receptors, promoting MP endocytosis (Terrisse et al., 2010). MP
surface IgM has also been shown to promote MP clearance by
macrophages (Litvack et al., 2011).
MP-Mediated Effects upon Vascular
Physiology
Although MP shedding may be enhanced by stress, exocytosis
is a constitutive process for the majority of blood and vascular
cell types (Angelillo-Scherrer, 2012). Depending on the stimulus,
however, protein content (of both “cytoplasm” and membrane)
for MPs derived from the same cell lineage can vary (Jimenez
et al., 2003).Moreover, the enzymes that governMP shedding can
be selective, depending on the activating agonist and/or parent
cell microenvironment (Peterson et al., 2008; Bernimoulin et al.,
2009). Such tight regulation of MP production suggests MPs
may facilitate important cell-cell communication in a context-
specific fashion. Of note, MPs are internalized by a variety of cells
(macrophages and endothelial cells, amongst others) in a dose-
dependent manner, enabling “MP cargo” transfer between cells
in a fashion that influences target cell function and phenotype
(Diehl et al., 2012).
The most well-characterized components of vascular
physiology that are influenced by MPs include the following:
Coagulation
This is perhaps the most clearly established example of MP-
based influence. Platelet derived MPs have effects similar to
activated platelets in initiation of thrombin generation and clot
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FIGURE 1 | Cellular microparticles: a mobile storage pool of bioactive effectors. Membrane microparticles are shed from the plasma membrane of stimulated cells,
harboring cytoplasmic proteins as well as bioactive lipids implicated in a variety of fundamental processes. MHC, Major histocompatibility complex; GPI,
glycosylphosphatidylinositol. Adapted with permission from Hugel et al. (2005).
propagation, despite having at least two-orders-of-magnitude
difference in surface area (Sinauridze et al., 2007). Moreover,
externalized phospholipids (mainly PS) create a negatively
charged surface that anchors cationic domains of proteins
involved in assembly of the multi-component (tenase) complex
that leads to the thrombin burst (Owens and Mackman, 2011).
Oxidative Stress
MPs of differing derivations, produced under various stimuli,
have been shown to affect the enzymatic systems controlling
reactive oxygen species generation. Both endothelial and
monocyte derived MPs are known to increase superoxide
(Mastronardi et al., 2011) and hydrogen peroxide production
(Burger et al., 2012) as well as to uncouple nitric oxide
synthase (NOS) (Essayagh et al., 2007). However, activated T-
cell related MPs have been shown to dampen reactive oxygen
species production and to increase nitric oxide (NO) production
(Agouni et al., 2007).
Inflammation
Pro-inflammatory signaling generally provokes MP shedding
and, in an amplifying signaling loop,MPsmay directly contribute
to the inflammatory response (e.g., PMN derived MPs promote
endothelial IL-6 and monocyte chemotactic protein release)
(Mesri and Altieri, 1999). MPs are also thought to promote inter-
cellular inflammatory cell interaction and adhesion; specifically,
endothelial-derived MPs increase adhesion molecule expression
and facilitate monocyte-endothelial cell interactions (Burger D.
et al., 2011), in addition to binding to monocytes and promoting
transendothelial migration (Jy et al., 2004).
Angiogenesis
Platelet-derived MPs have been implicated in regulation of
angiogenesis. In rats following myocardial ischemia, platelet MPs
increase post-ischemic capillary density, and proliferation (Brill
et al., 2005) and are reported to promote tube formation by
human umbilical vein endothelial cells (Kim et al., 2004). This
is not surprising, as platelets are known to contain at least 20
angiogenesis regulating factors. Moreover, certain stimulated T-
cell related MPs have been shown to inhibit angiogenesis both in
vivo and in vitro (Yang et al., 2012).
Apoptosis
Endothelial- and monocyte-derived MPs are described to
promote cellular senescence and apoptosis in circulating
angiogenic and endothelial progenitor cells, respectively (Huang
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FIGURE 2 | Size classes of extracellular vesicles. Exosomes are formed
through inward membrane budding, leading to formation of 40–100 nm
intracellular vesicles which accumulate within multivesicular bodies that are
subsequently released to the extracellular milieu. Apoptotic bodies may
contain DNA and/or organelles and are formed during the late stages of
apoptosis, after cell shrinkage. Microparticles are formed from the outward
blebbing of membrane and released into the extracellular space. Adapted with
permission from Burger D. et al. (2013).
et al., 2010; Distler et al., 2011). This process appears linked to
phagocytosis of MPs that contain high amounts of membrane
arachidonic acid, leading to caspase activation and initiation of
apoptosis (Huber et al., 2007).
RED BLOOD CELL (RBC) DERIVED
MICROPARTICLES (RMPs)
RBC-derived MP formation occurs routinely during normal
maturation in vivo; ex vivo, this process is accelerated by
processing and storage, prior to transfusion (Greenwalt, 2006).
RMPs are generally smaller than MPs of other origin, are
more homogenous in size (∼0.15µm in diameter), and are
often accompanied by smaller vesicles, termed nanovesicles
(Allan et al., 1980). During their 120-day lifespan, RBCs lose
∼20% of their volume through vesicle emission, increasing
intra-erythrocytic Hb concentration by ∼14%; metrics for RMP
production, circulating number and volume are presented
in Table 1 (Willekens et al., 2008). It was originally thought
that vesiculation served to rid RBCs (which lack lysosomes)
of damaged or harmful components that might otherwise
accumulate over time, such as denatured Hb, C5b-9 complement
attack complexes, or Band 3 neoantigens (Bosman et al.,
2008b). It has also been suggested that RMP shedding promotes
recognition and clearance of senescent and/or damaged RBCs by
removing integral self-marker membrane proteins (e.g., CD47)
(Stewart et al., 2005).
RMP Production
RBCs spontaneously shed PS-positive MPs (Burger P. et al.,
2013) and each individual RBC is estimated to generate ∼230
vesicles during it’s lifespan (Bosch et al., 1994). As for other
cell types, membrane phospholipid rearrangement is an integral
step in RMP formation. The normal asymmetric distribution of
the lipid bilayer is controlled by 3 different elements; flippase
(ATP-dependent enzyme that promotes inward orientation of
negatively charged lipids), floppase (responsible for maintaining
outward orientation of phosphatidylcholine) and scramblase
(facilitating bidirectional movement of all phospholipids)
(Daleke, 2003). Consequent to RBC injury, metabolic stress,
and/or senescence (and storage), ATP depletion and potassium
leakage diminish flippase activity, while elevated intracellular
calcium increases scramblase activity; consequently, normal
membrane asymmetry is lost, PS is exposed on the RBC
surface and vesicle shedding is promoted (Burger P. et al.,
2013). There is lack of consensus with regard to the RBC
sub-population most responsible for RMP production. Some
suggest that senescent RBCs are responsible for the majority
of RMP production in vivo (Willekens et al., 2003), while
others have shown that during storage (or other periods of
metabolic stress), younger RBC sub-populations produce the
majority of RMPs (Greenwalt, 2006). Of note, during storage,
RMP composition/content may vary with specific conditions and
duration (Piccin et al., 2015). For example, RMPs generated
in vitro, by stimulation with Ca ionophores, differ in size and
cytoskeletal protein structure than RMPs generated during RBC
storage (Allan et al., 1980; Salzer et al., 2002). Additionally,
RMPs isolated during storage have less variation in size
and shape than those isolated from circulation (Greenwalt,
2006). Moreover, hypotonic, alkaline storage solutions are
associated with increased RMP production and with an RMPs
that have diminished cholesterol, phospholipids, as well as
band 3 and protein 4.1 (Greenwalt, 2006). Leukoreduction
diminishes RMP production by up to 40–50%, particularly under
anaerobic conditions (Jy et al., 2012). More generally, RBC
storage (and other injury states) is characterized by progressive
depletion of energy resources and antioxidant defenses, enabling
accumulation of oxidative modification to proteins (and lipids),
particularly involving the cytoskeleton and Band 3 (Kriebardis
et al., 2008). Vesiculationmay enable elimination of suchmarkers
as well as other dysfunctional elements that accumulate during
storage, or consequent to in vivo injury (Delobel et al., 2012).
Triggers for RMP Production
Little is known about the specific signaling that regulates RBC
vesiculation, both during RBC aging in vivo and during ex vivo
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FIGURE 3 | Mechanisms proposed for cytoskeleton remodeling leading to microparticle (MP) formation. Under normal conditions, aminophospholipids
(phosphatidylserine and phosphatidylethanolamine) are found exclusively on the inner leaflet of the plasma membrane. During MP formation, membrane asymmetry is
lost as aminophospholipids redistribute to the outer leaflet of the plasma membrane. Cytoskeletal re-organization results in the outward blebbing of the plasma
membrane and may be dependent upon actin polymerisation, caspase 2/Rho kinase, calpain, and/or transglutaminase 2. Such processes may vary between different
cell types. MP formation appears to occur selectively in lipid-rich microdomains (lipid rafts/caveolae) within the plasma membrane. Adapted with permission from
Burger D. et al. (2013).
storage. Further, it is also important to recognize that unique
changes may occur to stored RBCs in vivo, following transfusion.
Several RMP production triggers have been identified, mostly
linked to (but not unique to) the changes RBCs undergo during
storage. These include:
a. Increased cytosolic calcium (Ca2+) is the most well-
characterized trigger for activation of Ca2+ dependent
proteases, leading to cytoskeletal damage and activation of
Ca2+ dependent scramblase; both processes are result in PS
exposure and MP shedding (Bevers et al., 1999).
b. ATP depletion impairs performance of the major ATP-
dependent transporter proteins (flippase and floppase)
responsible for maintaining cell membrane asymmetry; loss
of asymmetry promotes MP budding and shedding (Burger P.
et al., 2013).
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FIGURE 4 | Stimuli for microparticle (MP) formation from platelets, endothelial cells, and leukocytes. A summary of the stimuli which promote MP formation from
platelets, endothelial cells and leukocytes. NE, Norepinephrine; EPO, erythropoietin; sCD40I, soluble CD40 ligand. With permission from Burger D. et al. (2013).
TABLE 1 | Estimated total circulating number, volume and rate of production of RMPs, intact RBCs and their respective ratios in a healthy adult male (Willekens et al.,
2008).
Total circulating number Volume per RMP/RBC Rate of production
RMP RBC RMP RBC RMP RBC
Absolute number 8.5 × 108 2.5 × 1013 0.065 µm3 88 µm3 5.8 × 108/s 1.4 × 106/s
RMP: RBC ratio 3.4 × 10−5:1 7.38 × 10−4:1 8,120:1
c. Increased potassium (K+) leakage has also been linked
to disturbed erythrocytic membrane transporter activity,
disturbing maintenance of membrane structure and leading to
MP formation (Burger P. et al., 2013).
d. Other cascades arising from energy failure in RBCs have
been shown to increase RBC vesiculation and MP formation.
These include G protein-coupled receptor signaling, the
phosphoinositide 3-kinase (PI3K-Akt protein kinase B)
pathway, the Jak-STAT (Janus kinase-signal transducer
and activator of transcription) pathway and the Raf-MEK
(mitogen-activated protein kinase)-ERK (extracellular signal-
regulated kinase) pathway (Kostova et al., 2015).
RMP ∼ RBC Differences
Proteomic analysis demonstrates that RMP protein content
is diverse, including carbonic anhydrase, peroxiredoxins, and
14-3-3 proteins (regulators of a number of processes, such
as protein kinase activity and signal transduction) (Rubin
et al., 2008). RMPs, however, are structurally and functionally
different from intact RBCs (i.e., RMPs are not “just small
RBCs”). As discussed above, the RMP shedding process involves
loss of normal membrane asymmetry, with increased density
of negatively charged phospholipids (e.g., PS) on the outer
RMP membrane (leading to differing surface potential). In
comparison to parent RBCs, RMP membranes are also enriched
with specific proteins (Band 3 dimers) (Bosman et al., 2008b).
Moreover, in comparison to intact RBCs, storage-related RMPs
appear enriched with stomatin, relatively depleted in actin
and to have more stable glycophorin A (Rubin et al., 2008).
Disruption of normal cytoskeletal protein structure (de Jong
et al., 1996) is also integral to RMP shedding (Rubin et al.,
2012) and distinguishes daughter from parent cells. These
structural characteristics, in addition to size discrepancy, result
in important differential “streaming” between RBCs and RMPs,
with preferential RMP circulation in proximity to endothelial
cells in the “cell free” zone of the micro-circulation (Liu et al.,
2013) (N.B. This feature has significant physiologic implications,
vide infra.). Finally, RMPs encapsulate a significant amount
of Hb (Greenwalt et al., 1991), which confers physiologic
characteristics closer to cell free Hb than to intact RBCs
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[particularly with regard to interactions with nitric oxide
(NO)].
RMP Effects upon Vascular Physiology
There is increasing recognition of RMP biological effects,
particularly in the context of transfusion. Proposed effects
include the following:
Promotion of Coagulation
It is well-established that negatively charged surfaces activate
the zymogen components of the coagulation cascade, and it
appears that RMPs promote coagulation in this fashion. In
the presence of low exogenous tissue factor, RMPs increase
thrombin generation and remarkably, are capable of initiating
and propagating thrombin generation even in the absence of
tissue factor (Rubin et al., 2013). There is some evidence that
this pro-coagulant activity is dependent on Factor XII (Van Der
Meijden et al., 2012). Some authors have suggested that tissue
factor may be present on the RMP surface, contributing to their
pro-coagulant effect (Biró et al., 2003). Of note, RMP abundance
is known to increase in certain hypercoagulable states associated
with hypercoagulability, such as sickle cell crises (van Beers
et al., 2009). Conversely, RMPs also bind protein S, a cofactor
for activated protein C, which enhances degradation of Factors
VIIIa and Va, and inhibits tenase and prothrombinase and thus,
promotes clot lysis (Koshiar et al., 2014). As such, depending
on context, balance amongst these pleotropic effects determines
RMP “coagulation phenotype (Koshiar et al., 2014).”
Nitric Oxide (NO) Scavenging
Nitric oxide (NO) is a vasodilator effector component of
physiologic reflexes that subserve dynamic matching between
regional blood flow and tissue respiration (Doctor and
Stamler, 2011). Of note, extra-erythrocytic hemoglobin (Hb)
reacts with NO in a diffusion-limited oxidation reaction that
quenches NO bioactivity, disrupting vasoregulation and oxygen
delivery homeostasis; under normal conditions, this effect
is limited by Hb compartmentalization within RBCs (Singel
and Stamler, 2005). Specifically, constraints upon Hb∼NO
interaction are substantially influenced by RBC size and
membrane architecture (Huang et al., 2001); however, reaction
between de-compartmentalized, cell-free Hb, and NO lacks such
constraint (Lancaster, 1994). Notably, RMP:NO interactionmore
closely mirrors that of cell-free Hb than that of intact RBCs,
and as such—RMPs act as potent NO scavengers [RMP reaction
with NO is ∼1,000-fold faster than with RBC-encapsulated Hb
(Donadee et al., 2011) and is only 2.5- to 3-fold slower than
with cell-free Hb (Donadee et al., 2011)]. The potential impact
of quenching NO bioactivity by RMPs (following transfusion)
dramatically increases with the increase in RMP abundance that
is observed during storage duration. Of note, the degree by
which RMPs influence NO bioavailability in vivo is dependent
on several factors, most importantly, the degree to which
RMPs enter the cell-free zone in the microcirculation (e.g.,
stream in immediate proximity to endothelium) (Liu et al.,
2013).
Immune Modulation
Transfusion Related Immune Modulation (TRIM) is a
recognized, but poorly characterized, complication of
transfusion. Given the known increase in RMP generation
with storage duration, a role for RMPs in TRIM pathobiology
(which appears linked to RBC unit age) has been postulated
(Muszynski et al., 2017). RMPs influence antigen presenting
cells (APC) and boost mitogen driven T cell responses (Danesh
et al., 2014); specifically, RMPs amplify APC-based induction of
pro-inflammatory cytokines and chemokines from peripheral
blood mononuclear cells (PBMC), promoting their survival (pro-
inflammatory effect) (Danesh et al., 2014). Alternatively, RMPs
may exert an immunosuppressive effect, by dampening release of
various cytokines such as TNF-α, IL-8, or IL-10 (Sadallah et al.,
2008). Of note, production of sickle cell derived RMP (SS RMPs)
is enhanced during inflammation; moreover, when engulfed by
myeloid cells, SS RMPs promote pro-inflammatory cytokine
secretion and endothelial cell adhesion, suggesting that crosstalk
between circulating inflammatory cells and SS RMPs contributes
to sickle cell disease (SCD) pathogenesis (Awojoodu et al., 2014).
Additionally, since RMPs have also been demonstrated to bear
blood group antigens (Canellini et al., 2012); transfusion-related
RMPs may therefore represent a significant immunogenic
load (Willekens et al., 2008) and contribute to the severity of
alloimmunization in chronically transfused patients (Canellini
et al., 2012).
Promotion of Endothelial Adhesion
As noted above, RMPs appear to play a significant role in
the pathophysiology of SCD, during which RMP production is
enhanced, promoting pro-inflammatory cytokine secretion (van
Beers et al., 2009). SS RMPs have also been shown to enhance
adhesion of intact RBCs to endothelial cells (Awojoodu et al.,
2014). Of note, up to a third of the circulating extra-erythrocytic
heme in patients with SCD may be carried by RMPs (Camus
et al., 2015); moreover, externalized membrane PS on SS RMPs
retains heme on the external RMP surface; such heme-laden SS
RMPs transfer heme directly to vascular endothelium, generating
oxidative stress and endothelial apoptosis (Camus et al., 2015).
This linkage of hemolysis to endothelial injury has been proposed
as a trigger for SCD vaso-occlusive crises.
RMP Clearance
As for other MP populations, RMPs are likely to be cleared
via the MPS, by hepatic Kupffer cells (Willekens et al., 2005).
Such removal appears to occur very rapidly and is thought to
be mediated by PS-binding scavenger receptors and senescent
cell antigen specific autoantibodies (Willekens et al., 2005).
Immunologic analysis of RMPs elaborated by senescent RBCs
demonstrates Band 3 clustering; this RMP subpopulation may
therefore be cleared in a fashion similar to that for intact
senescent RBCs (Willekens et al., 2008).
RMPs and RBC Processing and Storage
for Transfusion
The RBC storage lesion is comprised by profoundly altered
metabolism and biomechanics; in particular, energy failure
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FIGURE 5 | Microparticle (MP) count in red blood cell units during storage
(without centrifugation). Data are expressed as the mean SD (n = 7). At day 5:
3,371,188 MPs/µL were counted, whereas at day 50: MPs had increased in
abundance by ∼20-fold. MPs were stained with anti-human CD47. With
permission from Rubin et al. (2008).
(with impaired ATP and reducing equivalent production) is
characteristic and is associated with a significant acidosis,
decrease in 2,3-diphosphoglycerate and failure of the membrane
Na+/K+ ATPase pump with continuous potassium leakage
(Bennett-Guerrero et al., 2007; D’Alessandro et al., 2015) (e.g.,
conditions known to promote RMP genesis; Bosman et al., 2008a;
Karon et al., 2009). Morphologically, stored RBCs slowly morph
from smooth biconcave discs, to spiculated echinocytes, to dense
sphero-echinocytes; these changes arise from membrane loss
and RMP formation, and lead to loss of cell volume regulation
and diminished deformability (Greenwalt, 2006), thus negaitvely
impacting post-transfusion survival and rheology (Relevy et al.,
2008). In fact, RMP genesis appears directly proportional to
storage duration, with a 20-fold increase after 50 days (Rubin
et al., 2008; Figure 5); the doubling time for RMP concentration
during storage is estimated to be 9 days (95% CI: 7.7–10.7 days)
(Donadee et al., 2011). The specific reasons for such significant
RMP production remain unknown; it has been suggested that
storage activates a physiologic process that serves (in vivo)
as means to prevent premature RBC clearance, by shedding
membrane proteins that would otherwise signal RBC senescence




Oxygen (O2) Delivery Homeostasis and
Vasoregulation
Tissue O2 delivery is a function of blood O2 content and regional
blood flow, with the latter being the principle determinant.
As such, the volume and distribution of regional blood flow
is actively regulated to maintain dynamic coupling between
O2 delivery and tissue respiration (Kulandavelu et al., 2015).
It is now commonly appreciated that RBCs act as both
sensors and transducers, comprising a signaling loop in this
physiology, by linking bioavailability of vasoactive effectors
in plasma to microcirculatory O2 gradients (and thereby,
modulating resistance vessel caliber to maintain perfusion
sufficiency) (Doctor and Stamler, 2011). This key physiologic
reflex is termed hypoxic vasodilation (HVD) and is primarily
mediated by RBC-transported NO (Gonzalez-Alonso et al.,
2001; McMahon et al., 2002; Doctor et al., 2005); as such, by
serving as HVD effector elements, RBCs function as a key node
in maintenance of O2 delivery homeostasis (Figure 6). This
paracrine RBC function is governed by O2-linked transitions
in Hb conformation which (because of differing reactions of
deoxy- and oxy-Hb with NO) transduce regional pO2 gradients
into NO bioactivity, thereby effecting vasodilation to resolve
perfusion insufficiency (e.g., HVD) (Singel and Stamler, 2005).
Of note, this physiology is disrupted when RBCs release Hb
into plasma. Specifically, although Hb packaging in RBCs blunts
NO consumption ∼1,000-fold, once released, free Hb (and RMP
contained Hb) readily inactivates NO, preventing facile NO-
based traffic between RBCs and endothelium (Vaughn et al., 2000;
Liu et al., 2013).
Transfusion and Vasoregulation
Mounting evidence indicates that RBC transfusion impairs
HVD efficacy, although the mechanism is not fully elucidated
(Bennett-Guerrero et al., 2007; Bonaventura, 2007; Reynolds
et al., 2011). In addition to the direct effects of cell-free
Hb upon NO bioavailability in plasma, transfusion-associated
hemolysis may also impair endothelial NO production via
release of arginase (which, via substrate depletion, constrains
eNOS activity) (Donadee et al., 2011; Alexander et al., 2013).
Moreover, processed/stored RBCs are 2- to 4-fold more avid NO
scavengers than fresh RBCs (Stapley et al., 2012) and exhibit more
pronounced inhibition of NO mediated vasodilation. Further,
mounting evidence implicates stored RBC-derived free-Hb and
Hb-rich RMPs in dampening normal NO bioactivity in the
microcirculation, leading to physiologically significant HVD
impairment (Chen et al., 2008; Donadee et al., 2011; Kim-Shapiro
et al., 2011; Roback, 2011). The latter observation is further
supported by in vivo data demonstrating RMP contribution to
the initiation of vasooclusive crises in SCD (Camus et al., 2015).
RMP Impact upon Vasoregulation
As discussed above, HVD is the principle physiologic reflex
that maintains dynamic coupling between regional O2 delivery
and tissue respiration, particularly during physiologic stress.
RMPs appear to impair RBC-based HVD support of O2 delivery
homeostasis, by: (1) preferential streaming in the cell free
zone of the microcirculation and (2) acting as an NO sink.
Specifically, animal studies demonstrate greater increase in mean
arterial pressure (MAP) upon infusion of cell-free supernatants
of longer stored RBC units (39 days) vs. fresher units (4 days)
(Donadee et al., 2011; Figure 7); this increase correlates with
the amount of extra-erythrocytic Hb (both free and in RMPs)
in supernatants. Moreover, RMP half-life in this model was
observed to be ∼15–20min, which is consistent with the time
course for blood pressure changes that occur with infusion
of stored RBC supernatants (Donadee et al., 2011). This is
particularly important since (unlike cell-free Hb), RMPs are not
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FIGURE 6 | Red blood cells (RBC) transduce regional O2 gradients in tissue to control nitric oxide (NO) bioactivity in plasma by trapping or delivering NO groups as a
function of hemoglobin (Hb) O2 saturation (Hb SO2). (A) Circulating NO groups are processed by Hb into the highly vasoactive (thiol-based) NO congener,
S-nitrosothiol (SNO). By exporting SNOs as a function of Hb deoxygenation, RBCs precisely dispense vasodilator bioactivity in direct proportion to the lack of regional
blood flow. (B) O2 delivery homeostasis requires biochemical coupling of vessel tone to environmental cues that match perfusion sufficiency to metabolic demand.
Because oxygenated Hb (oxy Hb) and deoxygenated Hb (deoxy Hb) process NO differently, allosteric transitions in Hb conformation afford context-responsive
(O2-coupled) control of NO bioavailability, thereby linking the sensor and effector arms of this system. Specifically, Hb conformation governs the equilibria among (A)
deoxygenated Hb FeNO (NO sink), (B) oxygenated SNO-Hb (NO store), and (C) acceptor thiols including the membrane protein SNO-AE-1 (bioactive NO source).
Direct SNO export from RBCs or S-transnitrosylation from RBCs to plasma thiols (D) yields vasoactive SNOs, which influence resistance vessel caliber and close this
signaling loop. Thus, RBCs either trap (A) or export (D) NO groups to optimize blood flow. (C) NO processing in RBCs (A,B) couples vessel tone to tissue pO2; this
system subserves hypoxic vasodilation in the arterial periphery and thereby calibrates blood flow to regional tissue hypoxia. Adapted with permission from Doctor and
Stamler (2011).
bound by haptoglobin and may therefore contribute significantly
to this phenomenon (Donadee et al., 2011).
SUMMARY
MPs are submicron particles that originate from varied cell
populations, that form in response to a multitude of stimuli
through cell membrane re-organization, blebbing and shedding.
MPs have pleotropic effects upon vascular physiology and
may serve as vehicles for inter-cellular communication. RMPs
form spontaneously during the RBC lifespan, with content
and cytoskeletal structure distinct from intact RBCs. RMP
production accelerates during RBC storage due to associated
biochemical changes: increased cytosolic calcium, ATP depletion,
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FIGURE 7 | Vasoactivity of infused packed red cell supernatant/plasma. (A) Experimental time line for packed red cell supernatant infusions. Rats were stabilized for
30min after surgery, and blood gasses were drawn as indicated (BG 1 and BG 2). Supernatant (1.6mL) of packed red blood cells stored for either 4 or 39 days was
infused for 40min, after which the rats were followed for 1 h (n = 5). (B) Change in mean arterial pressure (MAP) over time after packed red blood cell (RBC)
supernatant infusion and 60-min follow up. (C) Average percentage peak increase in MAP after infusion of packed RBC supernatants (RBC sup) (p = 0.003). (D)
Correlation (solid line) between packed red blood cell supernatant haeme concentration and percentage increase in MAP after 40-min infusion of packed red blood
cell supernatant stored for either 4 days (black solid circle) or 39 days (black solid square; R20.65). Each data point was obtained from a separate rat infusion
experiment, in a different rat (2 groups of n = 5). All values are displayed as mean standard error of mean (SEM). Student t-test was used to compare the 2 groups of
rats. Avg, average; conc, concentration. Adapted with permission from Donadee et al. (2011).
and increased potassium leakage. Moreover, RMP composition is
affected by the trigger for their formation and by different storage
conditions.
Proposed RMP biological effects include promotion of
coagulation, immune modulation, and enhanced endothelial
adhesion. Of particular importance, RMPs demonstrate
significant NO trapping/consumption, disrupting regional
matching between blood flow and tissue respiration that is
essential to oxygen delivery homeostasis physiology. These
effects have been demonstrated in animal models evaluating
storage related RMPs, which appear to provoke an increase in
systemic vascular tone and blood pressure following infusion of
cell-free RBC unit supernatants. This effect is progressive with
storage duration.
FUTURE DIRECTIONS
Our goals are to further elucidate the impact of RMPs on
vasoregulation in critically ill subjects. We are currently
examining the in vivo effects of RBC transfusions on
hemodynamics, systemic vascular resistance and cardiac
output, and tissue re-oxygenation during dynamic near infrared
spectroscopy (NIRS), a novel non-invasive means to monitor
hypoxic vasodilation (Creteur et al., 2009; Lipcsey et al., 2012).
Concurrently, we are quantifying the peri-transfusion change
in RMP burden and pharmacodynamics and the relationship to
plasma vasoactivity which will be correlated with dynamic NIRS
findings in humans.
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